NRX Pharmaceuticals Inc (NRXP)

NASDAQ
1.41
-0.07(-4.73%)
After Hours
1.42
+0.01(+0.71%)
- Real-time Data
  • Volume:
    280,430
  • Day's Range:
    1.35 - 1.45
  • 52 wk Range:
    1.15 - 26.24

NRXP Overview

Prev. Close
1.48
Day's Range
1.35-1.45
Revenue
-
Open
1.45
52 wk Range
1.15-26.24
EPS
-8.08
Volume
280,430
Market Cap
93.3M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
615,531
P/E Ratio
-
Beta
0.69
1-Year Change
-94.62%
Shares Outstanding
66,641,314
Next Earnings Date
-
What is your sentiment on NRX Pharmaceuticals?
or
Market is currently closed. Voting is open during market hours.

NRX Pharmaceuticals Inc News

NRX Pharmaceuticals Inc Company Profile

NRX Pharmaceuticals Inc Company Profile

Employees
0

NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellStrong SellStrong Sell
Technical IndicatorsStrong BuyBuyStrong SellStrong SellStrong Sell
SummaryStrong BuyNeutralStrong SellStrong SellStrong Sell
  • New test results show 2.5 times more successful than current COVID / respiratory treatments.
    0
    • New results showing 2.5 times more successful thsn other current post Covid respiratory treatments. 🚀🚀
      0
      • Over $20 again?
        0
        • Loading up for the next run up
          0
          • This stock will go down all broker don't have CFDs to sell stock
            1
            • Why this sprint is going on?
              0